Meijer D, Luiting HB, van Leeuwen PJ, Remmers S, Jansen BHE, Bodar YJL, Witteveen T, Schaake EE, van der Poel HG, Wondergem M, Busstra MB, Nieuwenhuijzen JA, Meijnen P, Brabander T, van Moorselaar RJeroenA, Hendrikse NHarry, Oprea-Lager DE, Roobol MJ, Vis AN. Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer. J Urol. 2021 Apr;205(4):1100-1109. doi: 10.1097/JU.0000000000001437. Epub 2020 Nov18. PMID: 33207138. Meijer D, van Leeuwen P, Oosterholt P, Bodar Y, van der Poel H, Hendrikse N, Donswijk M, Wondergem M, Vellekoop A, van Moorselaar R, Nieuwenhuijzen J, Oprea-Lager D, Vis A. Management impact of (18)F-DCFPyL PET/CT in hormonesensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2960-2969. doi:10.1007/ s00259-021-05222-5. Epub 2021 Feb 5. PMID: 33547552. Samim A, Tytgat GAM, Bleeker G, Wenker STM, Chatalic KLS, Poot AJ, Tolboom N, van Noesel MM, Lam MGEH, de Keizer B. Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments. J Pers Med. 2021 Apr 4;11(4):270. doi: 10.3390/ jpm11040270. PMID: 33916640. Wondergem M, van der Zant F, Broos W, Roeleveld T, Donker R, Ten Oever D, Geenen R, Knol R. (18)F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary results of treatment efficacy. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):521-531. doi: 10.1007/s00259-020-04782-2.Epub 2020 Jul 27. PMID: 32719916. Wondergem M, van der Zant FM, Broos WAM, Knol RJJ. MatchedPair Comparison of (18)F-DCFPyL PET/CT and (18)F-PSMA-1007 PET/CT in 240 Prostate Cancer Patients: Interreader Agreement and Lesion Detection Rate of Suspected Lesions. J Nucl Med. 2021 Oct;62(10):1422-1429. doi: 10.2967/jnumed.120.258574. Epub 2021 Feb5. PMID: 33547211. Oncologisch centrum Appelman L, Appelman P, Siebers C, Bult P, Go H, Schlooz M, Mann R. The value of mammography in women with focal breast complaints in addition to initial targeted ultrasound. Breast Cancer Res Treat. 2021 Jan;185(2):381-389. doi: 10.1007/s10549-020-059435.Epub 2020 Sep 30. PMID: 33000376. Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMeershoek-Klein, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020Dec 7. PMID: 33301740. Bakker N, Doodeman HJ, Dunker MS, Schreurs WH, Houdijk APJ. Improving postoperative outcome in rectal cancer surgery: Enhanced Recovery After Surgery in an era of increasing laparoscopic resection. Langenbecks Arch Surg. 2021 Dec;406(8):2769-2779. doi: 10.1007/s00423-021-02266-x.Epub 2021 Jul 26. PMID: 34312719. Baldewpersad Tewarie N, van Driel W, van Ham M, Wouters M, Kruitwagen R. Clinical auditing as an instrument to improve care for patients with ovarian cancer: The Dutch Gynecological Oncology Audit (DGOA). Eur J Surg Oncol. 2021 Jul;47(7):1691-1697. doi: 10.1016/j.ejso.2021.01.019. Epub2021 Feb 5. PMID: 33581966. Bogveradze N, El Khababi N, Schurink N, van Griethuysen J, de Bie S, Bosma G, Cappendijk V, Geenen R, Neijenhuis P, Peterson G, Veeken C, Vliegen R, Maas M, Lahaye M, Beets G, Beets-Tan R, Lambregts D. Evolutions in rectal cancer MRI staging and risk stratification in The Netherlands. Abdom Radiol (NY). 2021 Oct 4. doi: 10.1007/s00261-021-03281-8. PMID: 34605966. Bogveradze N, Lambregts D, El Khababi N, Dresen R, Maas M, Kusters M, Tanis P, Beets-Tan R. The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: Reproducibility, pitfalls and potential impact on treatment stratification. Eur J Surg Oncol. 2021 Sep 20:S0748-7983(21)00735-6. doi:10.1016/j. ejso.2021.09.009. PMID: 34583878. Wetenschappelijke publicaties 2021 | 94 Coelingh Bennink H, van Moorselaar J, Crawford E, Roos E, Somford D, Roeleveld T, de Haan T, van Melick H, Reisman Y, Zimmerman Y, van Osta G, Krijgh J, Shore N, Saad F, Schally A, Debruyne F. Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi). Eur Urol Open Sci. 2021 May 6;28:52-61. doi: 10.1016/j.euros.2021.04.005.eCollection 2021 Jun. PMID: 34337526. Derksen JWG, Vink GR, Elferink MAG, Roodhart JML, Verkooijen HM, van Grevenstein WMU, Siersema PD, May AM, Koopman M. The Prospective Dutch Colorectal Cancer (PLCRC) cohort: realworld data facilitating research and clinical care. Sci Rep. 2021 Feb 16;11(1):3923. doi: 10.1038/s41598-020-79890-y. PMID: 33594104. Dijkstra M, Nieuwenhuizen S, Puijk R, Timmer F, Geboers B, Schouten E, Opperman J, Scheffer H, Vries J, Swijnenburg R, Versteeg K, Lissenberg-Witte B, van den Tol M, Meijerink M. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers (Basel). 2021 Jun 2;13(11):2769. doi: 10.3390/cancers13112769. PMID: 34199556. Dijkstra M, Nieuwenhuizen S, Puijk R, Timmer F, Geboers B, Schouten E, Opperman J, Scheffer H, de Vries J, Versteeg K, Lissenberg-Witte B, Meijerink M, van den Tol M. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers (Basel). 2021 Oct 5;13(19):4997. doi: 10.3390/cancers13194997. PMID: 34638481. Gertsen E, Brenkman H, Haverkamp L, Read M, Ruurda J, van Hillegersberg R. Worldwide Practice in Gastric Cancer Surgery: A 6-Year Update. Dig Surg. 2021;38(4):266-274. doi: 10.1159/000515768. Epub 2021 Jun 1. PMID: 34062540. Groen W, Ten Tusscher M, Verbeek R, Geleijn E, Sonke G, Konings I, Van der Vorst M, van Zweeden A, Schrama J, Vrijaldenhoven S, Bakker S, Aaronson N, Stuiver M. Feasibility and outcomes of a goal-directed physical therapy program for patients with metastatic breast cancer. Support Care Cancer. 2021 Jun;29(6):3287-3298. doi: 10.1007/s00520-020-05852-9. Epub2020 Oct 26. PMID: 33104921.
95 Online Touch Home